Syndax Pharmaceuticals
SNDX
SNDX
68 hedge funds and large institutions have $176M invested in Syndax Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 33 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
+2
Holders Change %
+3.03%
% of All Funds
1.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
33
Reduced
14
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$2.9M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$7.06M |
| 3 |
3
BlackRock
New York
|
$22.8M |
| 4 |
CCI
4
Columbus Circle Investors
|
$497K |
| 5 |
5
Dimensional Fund Advisors
Austin,
Texas
|
$647K |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$5.08M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$12.8M |
| 3 |
GTC
3
Ghost Tree Capital
New York
|
$0 |
| 4 |
AG
4
Artal Group
Luxembourg
|
$1.79M |
| 5 |
BC
5
Boxer Capital
San Diego,
California
|
$1.17M |
